ZINZINO AB Announces Direct Share Subscription for Strategic Acquisition

ZINZINO AB: Share Subscription Through a Directed Set-Off Issue

On June 24, 2026, ZINZINO AB (PUBL.) announced significant updates regarding its stock structure and strategic acquisitions aimed at enhancing its market standing. This follows an authorization by the Annual General Meeting held on May 28, 2025, allowing the Board of Directors to initiate a directed share issue.

This strategic financial maneuver involved the issuance of 279,782 new B shares of ZINZINO, which were allocated to compensate claims against Truvision Health LLC. This transaction directly relates to the company’s acquisition of Truvy, which was previously communicated on September 25, 2025.

The impact of this share issue is notable; the total number of ZINZINO B shares will rise by 279,782, culminating in a new total of 34,052,606 B shares. Consequently, the overall share count of ZINZINO will increase to 39,165,998 shares. This development signifies a dilution effect of 0.71 percent when measured against the company's total shares post-issue.

In terms of financial metrics, the share capital is set to increase by a total of SEK 27,978.20, elevating the capital from SEK 3,888,621.60 to SEK 3,916,599.80. This financial growth is integral as ZINZINO aims to bolster its investment capabilities and expand its market reach.

Strategic Context

This directed share subscription is part of ZINZINO's broader strategy to solidify its presence in health and wellness sectors through acquisitions. The company recognizes the ever-growing demand for innovative health solutions, especially as global health trends shift towards preventative care and wellness products. By acquiring Truvy and integrating its offerings, ZINZINO aims to cater to a robust consumer base looking for effective health solutions.

Furthermore, ZINZINO's focus on expanding its share structure indicates a proactive approach to creating value for its stakeholders while simultaneously enhancing its market capitalization.

Looking Ahead

The company’s Chief Executive Officer, Dag Bergheim Pettersen, remarked on the importance of this strategic decision to pursue growth opportunities even in volatile market conditions. With insights from CFO Fredrik Nielsen, ZINZINO reinforces its commitment to both existing and prospective investors, assuring that the growth is sustainable and responsible.

As ZINZINO moves forward, investors will be keen to monitor how these developments play out in the marketplace and what additional strategies the company will implement to amplify its competitive edge.

For further inquiries or detailed information, ZINZINO encourages stakeholders to reach out or consult their website for updates. This transparency is a part of their commitment to responsible corporate governance and investor relations.

Conclusion

With the recent directed share subscription, ZINZINO AB is poised for growth and integration of new health solutions into its product lineup. The company's proactive steps signal a forward-thinking strategy, setting the stage for potential greater returns for its shareholders and a strong market position in the health sector.

For media inquiries, you may contact: